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ABSTRACT 
PREDICTION OF ADULT HEIGHT IN CHILDREN 
WITH GROWTH DISORDERS 
Irene J. Freeman 
1988 
The adult heights of 119 former patients from the Yale 
Pediatric Endocrinology Clinic were obtained and compared to 
their predicted heights. All of these patients were seen for 
evaluation of their growth. Adult height predictions were 
obtained with the Bayley-Pinneau and Roche-Wainer-Thissen 
methods as well as with the "Genel/Lenko Method" in which 
bone age and current height are the predictors. The 
Genel/Lenko method was found to have a larger error than the 
other two methods and to overpredict in most cases. The RWT 
method was the most precise, although often not the most 
accurate method. The largest diagnostic group in the series 
consisted of boys with constitutional delay; the RWT method 
was the most reliable for fhis group. 
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I. INTRODUCTION 
It has long been of interest to parents to try to 
estimate their children s adult height. Whether or not a 
child will reach the same height as his father or mother is a 
matter of at least passing interest in most families. For 
those who develop a serious interest in a career or sport 
which involves a height restriction (e.g., police, pilots, 
gymnastics, ballet or basketball), there may be concern about 
planning for such a goal. 
Similarity to peers is an important concern for 
children, especially during adolescence, when they are most 
likely to differ in stature and rate of development. Short 
stature may lead to feelings of anxiety and inferiority, 
resulting in withdrawal nr other undesirable compensatory 
behavior. Even normal shortness can be a cause for concern, 
because it is often perreived (by both children and parents) 
to have an adverse effect on a person's future. 
The personality development of children with 
hypopituitary growth hormone deficiency has been studied 
(Rotnem et al., 1977). These children were found to suffer 
from disturbances of identity formation, body image, and 
difficulties in the expression of feelings of aggression and 
incompetence. Such disturbances are believed to arise from 
social and emotional immaturity resulting from the nature of 
social interactions elicited by short stature. These 

2 
children were often treated in a manner suitable for much 
younger children, even by adults such as parents and health 
care personnel who were aware of their actual age and 
interested in treating these children appropriately. Parents 
were found to underestimate the developmental difficulties of 
these children and to treat them with overprotectiveness and 
a controlling parental style (Rotnem et al., 1977). 
For many years, the supply of human growth hormone was 
derived entirely from a limited supply of cadaver 
pituitaries, and its use was restricted to children with 
severe growth hormone deficiency. The supply was withdrawn 
in early 1985 after the deaths of four people who had 
received pituitary-derived GH were reported. The cause of 
death was Creutzfeld-Jacob disease, which is believed to be 
transmitted by infectious material from human brains. Six 
months later, the f i rst GH preparation produced with 
recombinant DNA technology (Protropin) was approved by the 
FDA for treatment of GH deficiency. This biosynthetic GH 
differs from native GH by one amino acid (containing an 
additional methionine) and has been shown to be effective in 
treatment of children with GH deficiency (Kaplan et al., 
1986). A second biosynthetic GH (Humatrope) is now 
available; its amino acid sequence is identical to that of 
endogenous GH. Although GH is no longer scarce, it is still 
very expensive; one year of treatment may cost over $13,000 
(Wilson and Rosenfeld, 1987). 
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The efficacy of treating children with growth hormone 
deficiency has been well established; however, its use in 
genetically short but otherwise normal children has not been 
clearly demonstrated. While there is evidence for some 
short-term increase in growth rate with GH treatment (Gertner 
et al., 1984), no long term benefit has been shown for such 
children. The possible side effects of GH treatment with 
pharmacologic doses in children who are not deficient are not 
known. Based on information from patients with acromegaly, 
side effects may include hypothyroidism, formation of 
potentially growth-limiting antibodies to GH, glucose 
intolerance, hyperlipidemia, and acceleration of 
atherosclerosis (Underwood, 1984). Therefore, the need for 
GH treatment should be assessed as carefully as possible. 
In addition to the medical concerns, there are 
considerable psychosocial issues as well. Society places an 
enormous value on height; it is a commonly held view that 
taller people are more successful, earn more money, and are 
more attractive than shorter people. The bias toward tall 
people may in fact be as widespread as racism and sexism, 
although its effects arc perhaps more subtle. It is 
inevitable that enormous pressure will be exerted on 
pediatricians to treat healthy children who are genetically 
short, or whose growth tempo lags behind the mean (in spite 
of an average ultimate height potential). In most cases, 
these children will be technically normal (taller than the 
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third percentile for age); however, their parents may be 
eager to protect them from the effects of "heightism". 
Parents may also seek treatment for children who do not meet 
expectations for athletic achievement, or even academic or 
social accomplishment, and in these instances, successful 
treatment seems unlikely, even if an increase in stature is 
achieved. 
In evaluating the risks and benefits of GH treatment, 
the possibly adverse psychosocial effect of undergoing 
multiple physician visits and receiving three injections 
every week should also be considered. In one study of 11 GH 
deficient children who received one year of GH therapy, the 
majority at least doubled their pretreatment growth rate. 
However, the increased growth was less than anticipated by 
the children and their parents (Rotnem et al., 1979). This 
"relative treatment failure" was manifested by an emergence 
of depressive themes in psychological testing which had not 
been apparent before treatment. Decreased self-esteem, 
withdrawal, and anger were also evident after treatment. 
Expectations of growth were believed to have been increased 
with extensive endocrine ^valuations and hospital admissions. 
Despite the children s disappointment, in most cases, 
physicians considered the treatment successful (Rotnem et 
al., 1979). In view of these findings, it seems that 
reliable prediction of adult height and expected treatment 
outcome are crucial to providing appropriate counseling to 
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children before undertaking a course of GH therapy. 
In addition to being used for evaluating the need for 
treatment and counseling patients, predictions of adult 
height have also been used to assess short-term effects of 
treatment of growth disorders (Colie et al., 1977, Martinez 
et al., 1987; Schoenle et al., 1987). While the only 
completely reliable means for evaluating the efficacy of 
treatment is to compare the adult heights of a treated group 
to those of a non-treated group, this requires years of 
followup and is often not practical. Since different 
prediction methods may produce different biases for certain 
groups, the choice of a prediction method could result in an 
erroneous demonstration of the efficacy of a treatment 
method. For example, if a prediction method tends to 
underpredict adult height for children of a certain age 
(e.g., when treatment begins), but not for later ages (e.g., 
when treatment ceases), then by comparing the adult height 
predictions before treatment (underpredictions) to after 
treatment (more accurate), a treatment method could be 
erroneously considered to be effective. 
An illustration of this is provided by a study in which 
height predictions were done before and after testosterone 
treatment of boys with constitutional delay, and adult 
heights were also obtained (Martin et al., 1986). Although 
pre- and post-treatment predictions were equivalent, the 
group which received the highest testosterone dose failed to 
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achieve their predicted heights by a statistically 
significant margin. This was due to a decreased growth rate 
after treatment ended. If the treatment had been evaluated 
solely on the basis of height predictions, high dose therapy 
would have been considered effective for inducing a growth 
spurt, when it actually was associated with a decrease in 
adult height. 
The height prediction methods currently in use were 
developed with data from normal children (with the exception 
of the method of Lyon et al. (1985) for Turner's Syndrome). 
The accuracy of the prediction methods for children with 
growth disorders must be assessed in order to evaluate the 
effects of treatment. 
Growth curves have long been used as indicators of 
disease and as a means of following patients with chronic 
di seases (e.g. congenita 1 heart disease , chronic renal 
insufficiency) . Patients who receive growth-inhibiting 
medications (e.g. steroids) also need to have their growth 
followed carefully. Management of these patients would be 
easier with reliable, accurate means of adult height 
prediction. 
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11. BACKGROUND 
A. Skeletal Age Estimation as a Measurement of Maturity 
All of the commonly used methods of adult height 
prediction include an estimation of skeletal age (or bone 
age). Because there have been many methods proposed for this 
purpose, a discussion of height prediction necessarily begins 
with a review of these methods. The concept of bone age 
originated as an attempt to quantify maturation. Bone age 
has been defined as the age at which the radiographically 
observed bone maturation is average (Schaff-Blass et al., 
1984). Maturity differs from other anthropometric 
measurements, such as stature, in that every individual 
progresses from a state of complete immaturity to one of 
maturity. Stature and other size measurements do not define 
maturity; a child who is "tall for his age" may be more 
mature than his peers, or he may simply be a tall child of 
average maturity who will be a tall adult. 
1. Atlas Methods of Skeletal Age Estimation 
The atlas methods involve comparison of a patient's 
radiograph (usually of the hand-wrist) to standard 
radiographs until one is found that matches the maturity 
level of the patient. The method was developed by Todd 
(1937) and others who developed atlases of standards for the 
hand-wrist, foot-ankle, and knee (Greulich and Pyle, 1959; 
Pyle and Hoerr, 1969; Hoerr et al., 1962). These standards 
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were derived from serial radiographs of white children of 
high socioeconomic status in Cleveland, Ohio. 
The Greulich and Pyle atlas has separate standards for 
boys and girls; the others have one set of standards with 
corresponding sex-specific bone ages. The Greulich and Pyle 
standards have been shown to be more advanced than samples of 
Finnish and Danish children as well as U.S. children between 
the ages of 9-13 years (Roche, 1986). This has been 
attributed to the high socioeconomic status of the study 
participants and to the unusual procedure used to establish 
the sex-specific standards. 
The atlas method i s most accurate when used to assign 
bone-specific ages which are combined to obtain the overall 
bone age. However, the more frequent technique of assessment 
is to obtain a subjective impression of which standard best 
matches the patient's radiograph. Because the bones in the 
standards themselves differ in maturity, this less systematic 
approach is likely to be less accurate than the bone-spedfic 
method. 
Intraobserver differences between repeated readings are 
about 0.5 years for experienced observers using the atlas 
method. Interobserver variances are about 0.8 years (Roche, 
1986). These differences are comparable to the standard 
deviations of about 10-12 months given with the standards in 
the Greulich-Pyle atlas. 
2 . Tanner Whitehouse Method 
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The bone age method used in the Tanner Whitehouse height 
prediction method (1983, see description on pp. 14-15) is 
called the "RUS bone age." It is obtained by assigning a 
numerical score to each of the 20 RUS bones (radius, ulna, 
and short finger bones); the average score provides an 
overall maturity estimate. Approximately nine 
radiographically defined stages are used as maturity 
indicators. This method was designed to quantify maturity 
more objectively than the atlas method. 
3. Roche Wainer Thissen Method 
Roche and colleagues developed a method for bone age 
estimation based on the assessment of 34 maturity indicators 
for the femur, tibia, and fibula. A computer program 
analyzes these and provides a skeletal age estimate with a 
standard error. Reliability is reported to be comparable to 
the RUS bone age and better than the hand-wrist atlas methods 
(Roche et al., 1975; Roche, 1986). For convenience, however, 
the RWT height prediction method uses the Greulich-Pyle hand- 
wrist bone age. No height prediction methods have been 
developed for use with the knee bone age. 
B. Methods of Height Prediction 
The ideal method for height prediction would be 
statistically reliable (i.e., both accurate and precise), 
inexpensive, easy, rapid (i.e., could be accomplished in one 
visit), applicable to a clinically relevant age group, and 
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applicable to different diagnoses (or have a known bias for 
different diagnoses). As discussed below, the various 
methods which have been proposed for clinical use vary in 
the degree to which they fulfill the above characteristics. 
Most methods provide data for accuracy and precision in the 
"standardizing group" (population with which the method was 
developed) and at least one "validating group" (not used to 
develop the prediction method). Accuracy is generally 
assessed by mean prediction error (predicted height minus 
adult height), and precision by the standard deviation of the 
mean prediction error. As expected, heights of children from 
the standardizing population are predicted with the greatest 
accuracy and precision. 
The most commonly used methods of height prediction are 
referred to by the following abbreviations: BP for the 
Bayley and Pinneau method (1952), RWT for the Roche-Wainer- 
Thissen method (1975), and TW2 for the method of Tanner, 
Whitehouse, and others (1983). 
1. Bayley-Pinneau Method 
This method is based on the high correlation between 
skeletal age and percent of adult height achieved. Children 
are divided into three groups: accelerated, average, or 
retarded in skeletal maturation, based on the difference 
between chronological age and skeletal age. Since the 
variation of chronological-skeletal age is continuous, the 
separation into three groups can cause large fluctuations in 
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serial predictions for children whose group membership 
changes between predictions. 
The BP tables are based on data from 192 normal children 
(103 girls and 89 boys) who were measured and x-rayed every 6 
months from 8 to 18 years (or until epiphyseal fusion 
occurred). The prediction errors and sample sizes for each 
of the three groups were not reported. 
The child's current height and Greulich-Pyle bone age 
are used to obtain the prediction. The method may be used 
for most girls with bone ages of 6.0-18.0 years and most boys 
with bone ages of 7.0-18.5 years (the ranges vary depending 
on which of the three groups the patient belongs to). 
Accuracy is increased with serial exams and x-rays; however, 
a single exam may be used. For normal children, the BP 
method is reported to be accurate to within an inch for about 
two-thirds of girls through age 12 and boys through age 14. 
After these ages, the prediction error was less than an inch 
for most children, decreasing to less than 0.5 inch after age 
13.5 in girls and 16 in boys (Bayley and Pinneau, 1952). The 
method has also been reported to underpredict in girls of all 
ages and to overpredict in boys at 7, 15, and 16 years (Roche 
et. al, 1975). 
The BP tables have also been published in the Greulich- 
Pyle atlas (1959) and have been summarized by Post and 
Richman (1981). A pocket height predictor has been prepared 
by Genentech (a major GH manufacturer) based on these tables. 
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2. Roche-Wainer-Thissen Method 
The RWT method predicts stature at 18 years; final adult 
stature can be predicted with correction factors. The method 
was derived using data from middle-class Ohio children born 
in 1929-1954. About 800 children were enrolled, with about 
100 of each sex in each age group. The children were 
weighed, measured, and x-rayed every 6 months until age 18, 
with biennial exams thereafter. 
A multiple regression equation is used to predict adult 
height from recumbent iength, skeletal age (median of 
Greulich-Pyle bone-specific skeletal ages (Greulich & Pyle, 
1959)), weight, and mid-parent stature. Although some of 
these variables contribute little to the adult height 
estimate, coefficients are given for all variables at all 
ages. Stature can be substituted for recumbent length with 
the use of a correction factor. Population means can also be 
substituted for other parameters, with some decrease in 
accuracy, depending on the importance of the particular 
variable for the particular age group. 
The method is applicable from 1-14 years in girls, and 
1-16 years in boys. It is designed to be used for children 
who have fewer than 50% of their hand-wrist bones judged to 
be mature; predictions for more mature children are felt to 
be unimportant because of their limited remaining growth 
potential. As a result, the RWT method is less accurate than 
BP for older children. Median absolute errors, in validation 
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samples, were generally less than 3 cm, and less than 6 cm 
for 90% of patients in both sexes. The accuracy of 
prediction, as a percentage of adult height, was slightly 
less for girls than for boys; however, since girls tend to be 
shorter than boys, the absolute errors of prediction were 
comparable. (This could become more important in predicting 
adult stature for girls with genetic tall stature.) The 
method was checked and compared to the BP method by applying 
both methods to two verification populations. The RWT method 
was found to be more accurate than BP except at older ages. 
The authors felt this may have been due to the inclusion of 
children whose hand-wrist bones were more than 50% mature. 
The median errors with RWT showed less variation with age 
than with the BP method; this was attributed to the use of 
more parameters in the RWT method, and the treatment of 
skeletal and chronological age as continuous variables. 
Prediction errors at puberty were notably smaller for RWT 
than BP, especially for girls (Roche et al., 1975). 
While providing accurate predictions for the tested 
populations over a large age range, the RWT method is 
considerably more complicated than the BP method. More data 
are required than for the BP method, and RWT is not 
applicable to more mature children. (It is even possible 
for the RWT equation to result in a prediction for an older 
child which is less than the child's current height.) Since 
children often present for growth evaluation around puberty. 
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this may be a drawback for clinical use. Although there may 
be little growth remaining for such children, accurate height 
prediction may still be very useful for counseling. 
3. Tanner-Whitehouse Method 
The TW Mark 2 Method (TW2) was published in 1983 (Tanner 
et al., 1983), as a revised version of TW Mark 1 (Tanner et 
al., 1975). The Mark 2 method is based on data from a 
standardizing sample which included 260 normal British 
children (110 boys and 150 girls) who were followed in 
longitudinal growth studies, as well as 63 children (34 boys 
and 29 girls) attending a Growth Disorder Clinic. These 
children were very tall, very short, or very delayed, but 
were free from gross pathological conditions. For most of 
these children, adult height was measured at home by a family 
member following written instructions. 
TW2 predictions are obtained with regression equations 
which use RUS bone age, chronological age, and stature as the 
variables. Separate equations are used for pre- and 
postmenarcheal girls. When available, equations use "increase 
in height during previous year" and "increase in RUS bone age 
during previous year" for ages at which this increases 
accuracy (11-15 in boys and 8-14 in girls). The method is 
applicable for boys from 6 to 18.5 years and girls from 5 to 
16.5 years. 
In the standardizing groups, TW2 is only slightly more 
accurate than TW1, but the range of children covered is 
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greater. Residual standard deviations are provided for the 
regression equations at each age; these range from 1.4 to 4.7 
cm for boys and 0.9 to 3.7 cm for girls. This allows each 
prediction to be made with limits (+ one standard deviation) 
associated with a 67% probability that the adult height will 
fall in the specified range. The standard deviations are 
smaller for the TW2 method than for RWT for children over age 
12; below age 10 the RWT method is better. At ages 10 and 11 
the methods are comparable. The method is designed to apply 
to tall, short, and delayed, as well as average children; 
however, no data are available on the reliability of TW2 
predictions for children with pathological conditions. 
The TW2 method provides an accurate means of estimating 
adult height for British children, including children whose 
rate of growth differs from their peers. However, since 
North American children are taller and mature at a slightly 
faster rate than British children (Tanner and Davies, 1985), 
the method may be less reliable for American children. It is 
not an easy method to use, since the RUS bone age estimation 
requires more time and effort than the Greulich-Pyle method, 
and prediction requires calculation with a regression 
equation. Like the RWT method, the TW2 method may result in 
predictions for older children which are less than their 
current heights. 
4. Other Methods 
Wilson et al. (1987) recently published a method for 
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predicting adult height for adolescents which incorporates a 
"Sexual Maturity Index” (SMI). The SMI is the patient's mean 
Tanner stage, and is used to adjust the patient's height 
percentile for rate of pubertal maturation. It is assumed 
that subjects maintain their adjusted height percentile 
through adolescence to adulthood. To estimate adult height, 
this percentile is extrapolated on a growth curve derived 
from data from 6768 healthy U.S. adolescents examined during 
1966-1967 as part of the National Health Examination Survey. 
The final adult heights of these subjects were not available, 
so the SMI method was compared to the BP and RWT methods to 
assess reliability. For boys, the SMI method predictions 
exceeded those of the standard methods by an average of 
1.9j+5.4 cm (BP method) and 1.8 + 4.9 cm (RWT method). The SMI 
predictions were less than those of the standard methods for 
girls, by an average of 1.9+2.8 cm (BP method) and 5.1+3.7 cm 
(RWT method).1 This method applies to both sexes from 12- 
17.5 years. 
The ease and relative lack of expense necessary to use 
this method are advantageous (no x-rays are necessary, and 
all data can be obtained during one examination). The method 
applies to a clinically relevant age group. Disadvantages 
include the fact that final adult heights were not available 
to check the accuracy of the method, and no data are yet 
1 Standard deviations of mean prediction errors 
indicated by _+. 
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available on the accuracy of this method for children with 
growth disorders. 
An earlier method which incorporated information about 
sexual development was that of Onat (1983). This method 
allows estimation of adult stature in girls, using height, 
midparental stature, Greulich-Pyle bone age, whether or not 
Tanner stage 2 has been reached, and whether or not menarche 
has occurred. (Weight was used in the multiple regression 
analysis, but was found to be noncontributory, and was 
dropped.) The standardizing sample consisted of 100 Turkish 
girls, mostly of high socioeconomic status; however, in some 
age groups, fewer girls were enrolled (17 girls at age 9.0). 
The method may be applied to girls ages 9.0-14.0, with little 
growth expected after age 14. Accuracy of the method 
compares favorably with RWT for the standardizing group; 
however, no data are available from a validation group. 
This prediction method appears to provide adequate 
accuracy; however, its use is limited to girls, and its 
applicability to Americans has not been established. 
Accuracy for early and late maturing children, and children 
with growth disorders is purely speculative. Since the RWT 
method can be used for a larger age range and for both sexes, 
clinicians are unlikely to switch to the Onat method with its 
more limited applications. 
Pediatricians generally use growth curves as a screening 
tool to indicate disease, not for adult height prediction. 
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In one study, however, growth curves were used to predict 
adult height (Lenko, 1979). Termed the "relative height 
method", the child's height was simply plotted on a growth 
curve and extrapolated to the adult height corresponding to 
the same percentile. Although children are believed to 
follow their own "growth channels", this method did not lead 
to good predictions of adult height; substantial 
overpredictions occurred at all ages for normal children as 
well as boys with delayed puberty (Lenko, 1979). One 
possible reason for the inaccuracy of the relative height 
method was that the growth curve used in this study was 
derived from cross-sectional data (based on measurements of 
different children at each age) rather than longitudinal data 
(based on repeated measurements of the same cohort of 
children over time). Actual growth patterns are slightly 
different than those seen in cross-sectionally derived 
curves. This becomes especially important in adolescence 
because children progress through puberty at different rates. 
Wilson et al. also used this method (called the "chart 
method") for adult height prediction and compared it to the 
SMI, BP, and RWT methods (Wilson et. al, 1987). They found 
the method to be quite accurate for adolescents maturing at 
the average rate; however, large errors were found when the 
method was used for children maturing either faster or shower 
than the middle group. 
A series of growth curves for North American children 
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was developed by Tanner and Davies (1985) which was based on 
longitudinal data and therefore better represents the actual 
shape of individual growth curves. The curves derived from 
cross-sectional data by the National Center for Health 
Statistics (Hamill et al., 1979) were shown to overestimate 
height for average boys by 2 cm at 13 years, and 
underestimate by 2 cm at 15 years. Tanner and Davies also 
constructed separate growth curves for early and late 
maturers (for whom the cross-sectional data are even less 
accurate). These curves are designed for use in following 
children's growth, not for predicting adult height. No 
studies are available which test the accuracy of the "chart 
method" with these growth curves. 
Walker developed a method of height prediction in order 
to provide standards for somatotyping children (Walker, 
1974). This method was developed from longitudinal data from 
healthy New Haven children (143 boys and 80 girls). 
Equations were derived using three combinations of variables: 
height and age alone, height, age, and growth rate over the 
preceding year, and the latter plus determination of whether 
or not the subject had passed his age of peak growth 
velocity. Predictions can be made for boys and girls from 2 
to 20 years. The average error in the validation sample was 
2-3 cm in boys from 9-14 years and girls from 8-12 years 
(Walker, 1974). No data were found regarding the use of this 
method in other populations. 
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The first method of height prediction specifically for 
girls with Turner's syndrome was based on data from four 
series of patients studied in Europe (Lyon et al., 1985). A 
total of 366 patients (both 45X and mosaic) from Germany, 
Finland, and France were included. A growth curve was 
obtained from the pooled data, and a regression equation 
derived for prediction. The only parameters necessary to use 
this method are age and height. The method was verified with 
data from 29 British patients who had been followed from 
childhood to age 19 to 24 years, and found to provide an 
adult height estimate with 95% confidence limits of the order 
of +2.0 cm. For 12 girls who had bone ages done at the time 
of initial evaluation, the method was found to be more 
accurate than the TW2 method: TW2 gave a mean error of +3.3 
cm (overprediction), compared to the mean error of the Lyon 
method of -0.6 cm (underprediction). The method can be 
applied to Turner's syndrome patients of all ages. No 
significant differences in mean height were found in this 
study between 45X and mosaic karyotypes. The applicability 
of the method to U.S. patients with Turner's syndrome has not 
been established; however, it is almost certainly more 
accurate than prediction methods which were developed using 
normal children. 
C. Comparison of methods of height prediction 
There have been several studies where the various 
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methods of height prediction have been applied to non¬ 
standardizing groups. These studies may be used to estimate 
the bias associated with prediction methods, thereby allowing 
corrections to be made when the method is applied to a non¬ 
standardizing group. 
In one study, a series of 60 healthy Finnish children 
(30 girls and 30 boys) was followed yearly from age 7 to 17 
years (Lenko, 1979). A second series of 7 healthy boys with 
familial delayed growth and puberty was followed in an 
Endocrine Clinic. The adult heights of these patients were 
compared to their predicted heights obtained using the 
following methods: BP, RWT, TW1, Walker, "Relative Height" 
(RH) method (described above), and "Index of Potential 
Height" (IPH) method (identical to the RH method except bone 
age was used instead of chronological age; referred to in 
this thesis as the "Genel/Lenko Method"). The Finnish growth 
standards used for the RH and IPH methods were cross- 
sectional . 
For the normal children, predictions with the BP, TW, 
and RWT methods were as accurate as for the standardizing 
series of the respective methods; the three methods were 
comparable in accuracy and precision. When bone ages were 
adjusted for differences between Finns and Americans, the IPH 
or Genel/Lenko method gave predictions comparable to the BP, 
TW, and RWT methods. For the boys with delayed growth and 
puberty, the corrected IPH, BP, and RWT methods gave the most 
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accurate results; all three methods were comparable and were 
more accurate than the TW method (Lenko, 1979). In a more 
recent study, 15 healthy Finnish boys with constitutional 
delay had adult height predictions made using the BP, RWT, 
and IPH methods (Lenko, 1982). The three methods were found 
to be comparable. 
Harris and colleagues (1980) compared the BP, RWT, and 
TW (1975) methods using longitudinal data from healthy 
American children (22 boys and 24 girls). The mean 
prediction errors (predicted height minus adult height) and 
variances of the error for the three methods were generally 
equivalent; however, the mean error for the BP method was 
more symmetric about zero than for the other methods, and was 
associated with a larger error. The RWT and TW methods 
tended to underpredict (as did the BP method for girls 11-12 
yrs). This underpredict.i on was felt to be partially due to 
the use of adult heights obtained in the subjects' twenties, 
rather than stature at 18 years or stature obtained when the 
subject's yearly growth was <lcm. Underprediction of the TW 
method was attributed to differences between American and 
British children in rate of maturation which were reflected 
in the skeletal age estimates. 
In a study of 56 normal Swiss children and 34 children 
with abnormal growth patterns, Zachmann and colleagues (1978) 
compared the BP, RWT, and TW1 methods of height prediction. 
The RWT and TW1 methods were found to be more accurate than 
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BP in normal children and in patients with familial tall 
stature. The BP method was felt to be preferable in 
conditions where decreased growth potential is untreatable, 
such as precocious puberty. Turner's syndrome, and primordial 
small stature. No statistics are given regarding the 
significance of the differences in accuracy between the 
various methods. The normal children were split into early- 
maturing, average, and late-maturing groups, but the data for 
each group are not presented. 
So far, there are no published data on the reliability 
of the TW2 method, other than that of the authors. In all of 
the studies discussed above, earlier versions of the Tanner- 
Whitehouse method were used. 
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III. HYPOTHESIS 
The Genel/Lenko Height Prediction Method 
The prediction method proposed for this study (the 
Genel/Lenko, or GL method) has been used informally for many 
years in the Yale Pediatric Endocrinology Clinic as an 
adjunct to established prediction methods, primarily for 
counseling purposes. The method was first published by Lenko 
(1979), who called it the "Index of Potential Height" (IPH) 
method. This method is described on pp. 21-22. In the Lenko 
study, Greulich-Pyle bone ages of Finnish children were 
adjusted for differences between Finnish and American rates 
of skeletal development, and a Finnish growth curve was used. 
For the current study with American subjects, Greulich-Pyle 
bone ages and growth curves provided by the National Center 
for Health Statistics were used (Hamill et al., 1979). 
The GL method is rapid, inexpensive, and easy (requiring 
no calculations or tables other than the growth chart), and 
can be used when other methods do not apply (e.g., wrong age 
group for BP tables, insufficient information for RWT). 
Experience with this method in the Yale Pediatric 
Endocrinology Clinic lias produced the clinical impression 
that it is comparable to the established methods in accuracy, 
although it is probably associated with a larger error. 
Lenko found the IPH (or GL) method to be comparable in 
accuracy and precision to the BP and RWT methods, and 
considerably more accurate than the TW method. For the same 
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population, predictions based on chronological age, height, 
and a growth curve (the "relative height" method) were 
inaccurate, indicating that the substitution of bone age for 
chronological age greatly improved the accuracy of 
prediction. This was true for normal children as well as for 
a group of boys with delayed puberty or delayed growth 
(Lenko, 1979). In a second study, the IPH method was again 
found to be comparable to BP and RWT for a group of boys with 
constitutional delay (Lenko et al., 1982). 
Wilson et al. tested the "chart method" which is 
identical to the "relative height" method of Lenko, except 
for the use of growth curves derived from data from American 
children. They found that this method worked well for 
children maturing at the average rate, but the method 
produced large errors when used for fast and slow-maturing 
adolescents (Wilson et al., 1987). Wilson and colleagues 
corrected for different rates of maturation by incorporating 
the SMI rating in their method. The GL method is similar in 
concept: substitution of bone age for chronological age is 
essentially a correction for the variation in maturation rate 
which is seen in normal adolescents, as well as children with 
growth disorders. Since the majority of the children seen for 
growth evaluation are normal except for growing at a slower 
tempo (e.g., children with constitutional delay, delayed 
puberty), adjustment of the growth chart for bone age is 
expected to correct for this slower rate of maturation and 
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provide a reliable prediction of adult height. 
While both of the Lenko reports consider the IPH 
method's applicability for boys with constitutional delay and 
delayed puberty, sample sizes were small and the method was 
not tested for girls or other groups of children with growth 
disorders. Wilson et al. tested their method on normal 
children only. In the current study of former patients in 
the Yale Pediatric Endocrinology Clinic, it is hypothesized 
that the GL method will provide accuracy comparable to BP and 
RWT methods for both sexes and a range of children with 
growth disorders. When applied to a wider range of children, 
the error associated with the GL method is hypothesized to 
be greater than the errors typically associated with 
established methods. 
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IV. MATERIALS AND METHODS 
A. Study Design 
Former patients who were seen in the Yale Pediatric 
Endocrinology Clinic for evaluation of short stature or 
growth failure were contacted and asked to provide a current 
measurement for this study. The charts of discharged 
patients were available beginning in 1971 (including patients 
who were initially seen before 1971, and were still being 
followed then). These charts were reviewed and potential 
subjects were selected who were born before 1967, were 
evaluated for short stature or growth abnormality (including 
tall stature), and had a bone age estimate. Due to time 
constraints, not all of the discharged patient charts were 
reviewed. They were reviewed alphabetically, with the A-M 
group completed. 
A total of 338 letters were sent to former patients who 
fulfilled the above criteria. The initial letter (see 
Appendix A) was followed by a telephone call during which the 
former patient was invited to participate in the study. 
Subjects were encouraged to come to clinic to be measured; 
however, those who were unable to do so were measured at home 
and returned a postcard with the measurement. The majority 
(61%) of patients contacted by letter were lost to followup, 
either because of a change of address or telephone, or 
because the patient did not keep the clinic appointment or 
return the home measurement postcard. An adult height was 
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obtained from 35% of patients contacted. The rate of return 
of postcards was improved by contacting subjects a second 
time by telephone; however, due to time limitations, most 
patients were not reminded. The results of the original 
letters are shown in Table 1. 
B. Measurements 
Of the 22 patients for whom a "clinic measurement" was 
obtained, 19 were measured by the author in the Yale 
Children's Clinical Research Center, using the Harpenden 
stadiometer. The method described by Tanner et al. (1971) 
was used: gentle upward pressure was applied under the 
mastoid processes to obtain the child's maximum stature. 
This technique has been shown to minimize the decrease in 
height which occurs over the course of the day (Whitehouse et 
al., 1974). One subject was too tall to be measured with the 
Harpenden stadiometer; she was measured using a doctor's 
scale. For all of these measurements, the average of three 
heights was used. The other two "clinic measurements" had 
been obtained during clinic visits (these subjects were 
followed to ages 21 8/12 and 23 years). The measurements 
were verified by telephone in one case and home measurement 
in the other. 
Home measurements were done according to written 
instructions which were patterned after the method used for 
the clinic measurements (see Appendix B). 
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C. Reported Height Data 
For many subjects, a "reported height" was available as 
well as the measured height. This reported height was given 
by the subject or a family member before measurement was 
done. In order to determine the accuracy of such reported 
heights, the mean reporting error (reported height minus 
measured height) was calculated for subjects measured in 
clinic and those measured at home. The data are shown in 
Table 2. The reported heights given by subjects were found 
to be very accurate, with a mean reporting error of 0.1 in 
(standard deviation 0.7 in). Subjects who were measured in 
clinic were slightly more accurate than those measured at 
home in reporting their heights, but the difference was not 
significant. Because subjects were found to accurately 
report their heights, former patients for whom a measurement 
was not obtained (but a reported height was available) were 
included in the study. An additional 35 people who had 
reported an adult height, but did not provide a measurement, 
were included in the data base. 
Reported heights provided by family members (usually 
parents) were found to be less accurate than those provided 
by subjects, with a mean reporting error of 0.4 in (SD 0.9 
in). Reported heights obtained from family members were not 
used. 
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D. Diagnoses 
Each patient's diagnosis was reviewed, and confirmed 
based on information in the chart. In cases where the 
working diagnosis changed after the initial evaluation, the 
revised diagnosis was used. Comprehensive reviews of 
diagnosis and treatment of growth abnormalities are available 
(Mahoney, 1987; Schaff-Blass et al., 1984). The most 
prevalent diagnoses in this series are listed in Table 3, and 
the principles underlying these diagnoses are reviewed 
briefly below. Although children diagnosed with 
constitutional delay, genetic short stature, and genetic tall 
stature are considered to have "growth disorders," these 
diagnoses actually represent normal variants. The 
classification of endocrinologically and genetically normal 
children into these categories is often based on judgement 
and clinical experience, rather than any clearly defined 
criteria. 
1. Constitutional Delay 
Children with constitutional delay are "late bloomers"; 
they mature slowly, completing their skeletal and pubertal 
development later than their peers. Birth weight is 
generally normal, with normal growth for several months 
followed by a decreased growth rate for several months. 
Growth velocity then increases and is normal for bone age 
during childhood, with the growth curve parallel to (and 
usually below) the fifth percentile. Bone age is roughly 
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equivalent to height age (the age at which the observed 
height is 50th percentile); both are significantly below 
chronological age. The adolescent growth spurt is delayed; 
however, final adult height and sexual development are 
normal. This diagnosis is more prevalent in boys than girls, 
and there is often a family history of delayed growth and 
development (Mahoney, 1987). 
2. Genetic Short Stature 
Genetic (or familial) short stature is diagnosed when 
there are parents or other healthy close relatives who are 
short, the child's projected adult height falls within 10 cm 
of the average parental height percentile, and the growth 
rate is normal. Birth weight tends to be low, but is 
consistent with the family history, and there are no findings 
suggestive of congenital dysmorphic syndromes. Turner's 
syndrome is generally excluded for girls. Bone age is 
consistent with chronological age, and height age may be 
several years younger than chronological age (Mahoney, 1987). 
2. Constitutional Delay and Genetic Short Stature 
Constitutional delay and genetic short stature may 
coexist in the same patient. In these instances, a family 
history of short stature and growth delay may be obtained. 
Bone age is less than chronological age, and height age is 
intermediate between the two. 
3. Growth Hormone Deficiency 
The diagnostic criteria for growth hormone deficiency 
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have undergone a revision in recent years. Classic GH 
deficiency is defined as a GH response of less than 7ng/ml 
following two standard GH stimulation tests (Wilson and 
Rosenfeld, 1987). Some children who are not classically 
deficient may show accelerated growth with GH therapy, 
however, it is not clear how to predict which nondeficient 
children will respond (Gertner, 1988). 
4. Genetic Tall Stature 
The vast majority of children who are evaluated for tall 
stature are female, presumably for social reasons. Genetic 
tall stature is accompanied by a family history of tall 
stature and a normal growth rate parallel to the median 
growth curve (and above the 95th percentile). Bone age is 
comparable to chronological age, and height age exceeds both 
of these values. 
E. Predictions 
For patients who had more than one prediction made, the 
first one was used. In a few cases, the first available 
prediction data were not applicable for all prediction 
methods (e.g., the bone age was too retarded for use in the 
BP method), so the earliest set of data which applied to the 
greatest number of prediction methods was used. Each 
prediction was recalculated, using data from the chart. The 
bone age values used for prediction were the values reported 
in patient charts; the films were not available for re- 
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reading. 
Height predictions were carried out as follows: 
1. Genel/Lenko Method 
These predictions were obtained by following the 
procedure described on p. 24. 
2. Bayley Pinneau Method 
The tables provided by the authors (Bayley and Pinneau, 
1952) were used. 
3. Roche-Wainer-Thissen Method 
The authors' instructions were followed as closely as 
possible (Roche et al., 1975). A few modifications were used 
as recommended. Parental heights were obtained by report 
instead of by measurement. Stature was converted to 
recumbent length by adding 1.25 cm. The value resulting from 
the regression equation (height at 18 years) was corrected to 
obtain "truly final adult height" since the study 
participants were selected for age greater than 20 years. 
The bone age used was that of Greulich and Pyle (1959), but 
was not the median bone-specific estimate recommended by the 
authors. Instead, it was obtained by comparison to 
radiographs representing modal skeletal development. 
In three cases, population means were substituted for 
the heights of one or both parents, and in one case, the 
chronological age was substituted for bone age. All of these 
subjects were over 12 years old when the predictions were 
made; parental height and bone age are felt to contribute 
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little to accuracy of prediction at that age (Roche et al., 
1975). 
4. Other methods 
The TW2 method was not used because the RUS bone age 
method is considerably more complicated than the Greulich- 
Pyle method. Most of the bone age films were not available 
for re-assessment using this technique, so it was not 
possible to test the TW2 method. 
F. Statistics 
For each subject, a "prediction error" (predicted height 
minus actual adult height) was calculated for each of the 
prediction methods used. Mean prediction errors and standard 
deviations were calculated for each method using standard 
statistical techniques. The mean prediction errors (+ one 
standard deviation) corresponding to various diagnostic 
groups were graphed for each method (see Figures 1-12). The 
absolute values of the individual prediction errors are 
plotted against age at prediction in Figures 13-18. 
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V. RESULTS 
A. Study Participants 
The diagnoses of participants in the study are shown in 
Table 3. The population from which these subjects were drawn 
has been characterized in a 1978 Yale M.D. thesis. This was 
a comprehensive review of the charts of patients who were 
evaluated for short stature during 1971-1976 (Finch, 1978). 
The patients seen during this time were diagnosed as shown in 
Table 4. Comparison of data in Tables 3 and 4 reveals that 
there are fewer boys with constitutional delay and combined 
constitutional delay and genetic (familial) short stature in 
this study than there were in those patients seen in clinic 
during 1971-1976. For girls, this study had about twice the 
expected number of constitutional delay subjects as expected 
from the Finch data, and far fewer combined constitutional 
delay and genetic short stature subjects. The number of 
subjects with genetic short stature appear to be comparable 
for both groups. 
The reasons for these population differences are not 
clear. Because a significant fraction of the group being 
studied here was evaluated after 1976, recent changes in 
diagnosis could have contributed (e.g., changing criteria for 
diagnosing GH deficiency). There may also have been a 
diagnosis-related selection bias, with patients from some 
groups being less willing to participate in the study. The 
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most likely explanation, however, is that the differences are 
random, due to the relatively smaller sample in this study, 
and the large fraction of former patients lost to followup. 
The mean age at prediction for boys was 13.7 (SD 2.1) 
years, for girls it was 12.9 (SD 2.1) . The age distribution 
of study participants is compared to that of patients seen in 
clinic during 1971-1976 in Table 5. 
The mean adult heights for study participants in the 
different diagnostic groups are shown in Table 6. Population 
means are included for comparison; most of the groups in this 
study attained a mean adult height within two standard 
deviations of normal for the general population. 
B. Reliability of Prediction Methods 
As shown in Figure 1, all three methods were found to 
overpredict for boys. When the boys who had a prediction 
made with all three methods were analyzed (Figure 2), the 
same trends are seen. The BP method is the most accurate, 
with a mean error of 0.3 inches, although the mean error for 
the RWT method (0.5 inches) is comparable, and the RWT method 
has a smaller standard deviation. The Genel/Lenko mean 
overprediction of 1.4 inches is considerably greater than 
those of the other methods. It also has a larger standard 
deviation. 
Boys with constitutional delay represent the largest 
diagnostic group in this study. As shown in Figure 3, the 
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most accurate method of prediction with the smallest standard 
deviation is the RWT method. The BP method is reasonably 
accurate; however, the GL method has the largest error 
(overpredicts by 1.7 inches) and the largest residual (SD 3.0 
inches). Even if the bias of the mean error were used to 
correct predictions, the large standard deviation makes this 
method less reliable than the other methods for clinical use. 
There was one subject in this group (J.C.) who was evaluated 
when he was only 5.9 years old, much younger than the rest of 
the boys with constitutional delay (for whom the mean age at 
prediction is 14.0 years, S.D. 2.2 years). Since the GL 
method overpredicted his adult height by 11.8 inches 
(compared to the mean prediction error of 1.7 inches), it was 
felt that this may have been due to inaccuracy of the bone 
age estimate at such a young age. Therefore, the boys with 
constitutional delay were analyzed without this subject; 
results are shown in Figure 4. The deletion of this subject 
decreases the mean prediction error for the GL and RWT 
methods (the subject was too young to have a BP prediction 
made but did have a RWT prediction); the effect is much 
greater for the GL method. (The error of this subject's RWT 
prediction was only 1.9 in.; the decrease from the GL error 
is probably due to the use of additional variables.) There 
is also a considerable decrease in the standard deviation for 
the GL method; a small increase is seen for the RWT method. 
In spite of these changes, the relative accuracy and 
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precision of the methods are the same: the RWT method is 
superior to both other methods, and the GL method is clearly 
inferior. 
In contrast, for those boys diagnosed with both 
constitutional delay and genetic short stature, the 
Genel/Lenko method is roughly comparable to BP in accuracy 
and precision (see Figure 5). However, the RWT method was 
again found to be the most accurate as well as the most 
precise for this group, and would probably be the method of 
choice if convenience and expense were not a consideration. 
For boys with genetic short stature only, the GL and BP 
methods provided comparable accuracy, with the BP method 
being slightly more precise (Figure 6). The RWT method has a 
greater mean error than GL, but precision of the two is 
comparable. 
Results for boys with growth hormone deficiency are 
shown in Figure 7. Because this group was very small, the 
results are not very meaningful. 
The data for all the girls in the study are shown in 
Figure 8; Figure 9 shows the results for girls who had a 
prediction made with each method. Differences between the 
two graphs are minimal. The GL and RWT methods were found to 
overpredict, while the BP method underpredicted by an average 
of 0.3 inches. All three methods have comparable standard 
deviations, which were smaller than those found for the boys 
for two methods (GL and BP); the RWT method was both more 
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accurate and more precise for the boys. 
When analyzed by diagnostic group, there is no group of 
girls with more than 8 subjects, making it difficult to draw 
conclusions that are likely to be upheld in larger studies. 
Figures 10, 11, and 12 show the data for girls with 
constitutional delay, genetic short stature, and genetic tall 
stature respectively. The girls with genetic tall stature 
are the exceptions to every trend; this is the only group for 
which the GL and RWT methods do not overpredict and the BP 
method does not underpredict. Since this is the only group 
that was evaluated for tall stature, it is not surprising 
that the mean prediction error is in the opposite direction 
from that of the other groups. 
It has been shown for all of the major prediction 
methods that accuracy improves with increasing age (Bayley 
and Pinneau, 1952, Roche et al., 1975, Tanner et al., 1983). 
As shown in Figures 13-18, the absolute value of the 
prediction error decreases with increasing age for all three 
methods being considered in this study. This decrease in 
error is much more dramatic for the boys than the girls. 
Since the data shown in Figures 13-18 are cross-sectional, 
they are more difficult to interpret than if they were 
longitudinal. (For example, someone whose prediction error 
was 5 inches when evaluated at age 14 may have had an even 
greater error if a prediction had been made at a younger age; 
the appearance of these graphs may be deceiving.) 
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C. Psychosocial Effects of Unusual Stature 
While recruiting subjects for this study, an attempt was 
made to contact by telephone each of the 338 former patients 
to whom an introductory letter was sent. A variety of 
reactions was encountered when these former patients (or 
their parents) were reached. The vast majority of people 
were polite and helpful, and many were eager to discuss their 
experiences with growth evaluation and the adjustment to 
their height. During these conversations it became clear 
that for many patients the issue of stature had been one of 
acute importance during childhood and adolescence, sometimes 
continuing into adulthood. Because the comments from former 
patients and their families were completely spontaneous--no 
systematic effort was made to elicit them--the following 
observations are purely anecdotal. However, because 
psychosocial issues are so important in bringing many of 
these children to medical evaluation, it seems relevant to 
include this aspect of followup. The following discussion 
contains quotations which were generally taken from notes 
made during conversation; however, some were from memory, and 
were recreated to reflect the spirit of the remarks. 
Although negative reactions were infrequent, when they 
occurred they tended to be quite strong. People who refused 
to participate in the study were more likely to express 
negative feelings about their adult height or their treatment 
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at Yale than those who agreed to participate. Almost 
entirely from males, negative responses were generally 
expressed as disappointment with not reaching the expected 
height. In one case, the subject had attained a height 
within the predicted range, but remembered the prediction as 
being greater than it actually was; he expressed feelings of 
having been misled. 
A female participant, N., had been evaluated for short 
stature at age 17, after receiving hormonal therapy from 
another doctor to induce a growth spurt. She expressed 
strong concerns about the emotional aspects of this 
treatment. She said that her parents' concern about her 
appearance and desire to prevent her from having difficulties 
they experienced had led them to seek treatment which she 
felt was more detriments] than beneficial. The treatment 
included rhinoplasty to alter a nose which N. said "looked 
like Barbra Streisand's," and the hormonal treatment which 
was stopped when her voice became deeper. Fifteen years 
later, issues of body image appeared to still be salient. 
She said that she had become very close friends with a woman 
who was over 6' tall, partly because they shared many 
feelings about being different. N. expressed resentment of 
societal pressure to conform to others' expectations. While 
many of her concerns (unnecessary rhinoplasty, weight 
control) were not directly related to her short stature, she 
clearly considered them to be closely related. 
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J., a female who had been seen for short stature, said, 
"There is nothing wrong with me!" when first contacted. In 
spite of her assertion of normality, J. stated that her 
"children will be normal because their father will be over 6' 
tall". 
The parental desire to avoid bringing up painful 
memories of the short stature evaluation was apparent several 
times. One mother refused to tell her son about the study, 
saying, "Nothing was accomplished by his clinic visits, and 
he is still very sensitive about his height." She said that 
he has a Ph.D in Physics, is "brilliant”, and she hopes "he 
finds a nice short girl!" 
In spite of the perceived link between tall stature and 
success, the vast majority of former patients seemed to be 
leading active, productive lives involving school or careers, 
families, and community activities. (However there were two 
men in the sample who were unable to be measured because they 
were in jail.) The over-reporting of adult height, which one 
might expect in this population, was minimal (see Table 2). 
It was common for those who achieved their predicted height 
to be quite pleased, even if the prediction was relatively 
modest. 
One mother of a boy with constitutional delay (who grew 
to 5'10") said, "We prayed every day that he would grow and 
now he's taller than his dad! He owes it to Yale to come in 
and be measured. 
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Another boy with constitutional delay had several 
predictions made, and grew to 5'3", although most of his 
predictions were greater than this. He expressed very 
positive feelings about his care in clinic, and joked, "You 
should see my wife. She's 6'2" ! " (Coincidentally, his wife 
was encountered several weeks later, and was noted to be of 
medium height, perhaps 2-3" taller than her husband.) 
G., a boy with constitutional delay who grew to 5'5", 
expressed satisfaction with his evaluation and treatment with 
oxandrolone. Although he was certainly informed at the time 
that oxandrolone would not increase his ultimate height, the 
growth spurt provided by the treatment was apparently 
beneficial. He was optimistic that height restriction would 
not prevent him from joining the police force. 
The mother of S., a girl with genetic tall stature who 
had been called "Moose" in high school, described her 
daughter as a "stunning" woman who runs a lot, carries 
herself well, and models for a tall women's clothing store. 
In spite of this excellent adjustment, when this mother 
reported a recent measurement of 6'1" she said she didn't 
"want to know if S. is taller than this". Another girl with 
genetic tall stature exhibited a similar sort of denial when 
she said she did not believe a recent measurement of 5'8.5" 
and said that she had never wanted to be more than 58". 
When measured for this study, she was almost 5'9". 
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VI. DISCUSSION 
The retrospective nature of this study imposed several 
methodological limitations. The following discussion 
outlines some of these. 
A. Sources of Error, General 
1. Skeletal Age Estimation 
Many of the subjects in this study had bone age 
estimations done before coming to Yale for evaluation; 
variations in both technique and interpretation can be 
expected to result from this. (Outside bone ages were re¬ 
read by Yale radiologists whenever possible, but in a few 
cases the radiograph was not available, and the reported bone 
age was simply recorded in the chart.) As discussed above, 
bone age estimation is a subjective assessment requiring an 
experienced observer. A small difference in bone age may 
cause a large difference in height prediction, especially 
during the pubertal growth spurt. Many of the patients in 
this study were evaluated near the time of this growth spurt. 
2. Error of Measurement 
The error associated with measurements done in clinic 
using the Harpenden stadiometer is estimated to be less than 
3 mm (Tanner and Davies, 1985). Each subject in this study 
was measured three times, and the measurements were always 
within this limit. Those subjects who were measured at home 
were asked to perform three measurements; not all subjects 
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did. However, among those who did report three measurements, 
they were consistently within a 0.25 inch range. The error 
associated with the non-measured heights (reported values) is 
expected to be greater than with the measured values; 
however, as discussed earlier, the reported heights were 
found to be quite accurate when both values were available 
(Table 2.) 
3. Diurnal Variation 
It is well known that height decreases as the day 
progresses. Ideally, all subjects would have been measured 
shortly after getting up, however, for practical reasons, 
this was not possible. About one third of measured patients 
(clinic and home measurements) were measured within 2 hours 
of getting up. The mean difference between morning and 
afternoon or evening heights has been reported to be 0.6 cm 
(0.2 in) in one study; other studies have found average 
differences of 0.2-1.54 cm (0.08-0.6 in) between morning and 
evening measurements (Buckler, 1978). Since most of the 
measurements done on children in the Pediatric Endocrinology 
Clinic were done more than 2 hours after arising, and these 
measurements were used to obtain the predictions, the degree 
of increased accuracy that could have been achieved by 
measuring the adult subjects early in the morning is probably 
not clinically significant. 
4. Typographical Errors 
Typographical errors and errors of transcription in the 
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medical records are inevitable. There was enough redundancy 
in the charts to allow several errors to be corrected, but it 
was not possible to double-check most of the data (such as 
heights and weights obtained during clinic visits). 
5. Post-prediction events 
Patients who experience a severe illness or accident 
after a prediction has been made might end up with an adult 
height that is quite different from the predicted height. 
For the patients in this study, a change in management of a 
disorder which resulted in growth evaluation might 
drastically alter the later growth. For example, a diabetic 
patient who was considered to be in good control at the time 
of her growth evaluation in early puberty later became less 
well controlled, possibly causing a decrease in adult height. 
Growth hormone deficient patients who become non-compliant or 
lose access to growth hormone (the patients in this study 
were receiving growth hormone when it was very scarce and 
sometimes unavailable) might experience a significant loss of 
growth potential as well. 
6. Age 
The participants in this study were older than those 
presenting for growth evaluation in the Pediatric Endocrine 
clinic. The mean age at height prediction in this study was 
13.5 years, and the distribution of subjects by age is shown 
in Table 5. For comparison, this table also shows the age 
distribution of patients seen in clinic during 1971-1976. 
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The older age group represented in this study is believed to 
be due to the fact that the charts of discharged patients 
date back only to 1971. Patients born after 1967 were 
eliminated, so those who were seen more recently at a younger 
age were not old enough to be selected for the study, skewing 
the age distribution toward older patients. 
Because the accuracy of height prediction improves with 
advancing age for every method (Bayley and Pinneau, 1952, 
Roche et al., 1975, Tanner et al., 1983), this age 
distribution may produce a false increase in accuracy of 
height predictions. This should not favor any one method 
more than the others; however, it does limit the conclusions 
that can be made about applying these methods to children 
with growth disorders who are younger than those included in 
this sample. 
7. Use of Prediction Methods 
Not all subjects had predictions made with each of the 3 
methods being studied. If a particular subject was 
especially unusual (e.g., erroneous bone age, diagnostic 
error or aberrant growth pattern), and the data were 
applicable to only one of the methods, this could increase 
the mean error for that particular method. Such differences 
could have a significant effect in the smaller groups. 
8. Population differences 
The major difference between this series and the 
populations of normal children used to devise the published 
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methods of height prediction is that these children were 
diagnosed with growth disorders. Information is not 
available to retrospectively determine such characteristics 
as socioeconomic status, ethnicity, or other factors which 
may differentiate this study sample from the populations 
studied by others. In one study of 223 New Haven children, 
they were found to be taller than the U.S. national averages; 
however, the amount of this difference was not stated 
(Walker, 1974). 
B. Sources of Error Specific to RWT method 
All three methods being compared in this study used the 
subject's height at evaluation and bone age. The RWT method 
incorporates additional variables and therefore has more 
sources for potential error, although these parameters are 
not equally important at all ages. 
1. Skeletal Age 
The RWT method uses a bone age which is the median bone- 
specific Greulich-Pyle bone age estimate. Children with 
greater than 50% mature hand-wrist bones were excluded. 
Since the Greulich-Pyle bone ages used for the patients in 
this study were not estimated with the bone-specific 
technique, it is not known how many subjects were too mature 
to be evaluated with this method, or how much accuracy may 
have been lost by not using the bone-specific technique. 
2 . Parental stature 
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The authors of the method recommend measuring both 
parents and correcting heights to a "30-year value" (assuming 
a shrinkage rate of 0.06 cm/yr. for each year after 30). 
Because it was impractical to measure parents as well as 
subjects (and this was not a routine part of the growth 
evaluation in clinic), values reported in the chart or 
obtained by telephone were used. It was felt that many 
people do not revise their reported height for shrinkage 
after age 30, so that the reported values probably represent 
the parents' maximum heights. 
Parents who experienced a severe illness or accident 
during childhood may not have attained their full height 
potential, thus causing a falsely low height prediction. 
In three cases, one or both parents heights were not 
available. As recommended by the authors, population means 
were substituted for the missing data. One of these children 
was diagnosed with genetic short stature, so the population 
mean may not be representative in this case. This is 
unlikely to have a significant effect on the overall accuracy 
of the RWT method, and in fact, is quite representative of 
the way this method is probably used in clinical practice. 
Because parental height contributes little to overall 
prediction accuracy after age 16 in boys and 13 in girls, and 
the mean ages at prediction in this study were 13.7 and 12.9 
for boys and girls respectively, these modifications of the 
procedure for determining parental height are not believed to 
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have significantly decreased the accuracy of these 
predictions. 
3. Recumbent Length Correction 
The mean difference between recumbent length and stature 
varies with age, and is different in different studies 
(reported range, 0.3-1.5 cm). There is evidence that the 
correction factor varies with different methodology, and 
should be established for each investigation (Roche & Davila, 
1974). For this study, the correction factor recommended by 
the authors was used, since it was impossible to check 
retrospective data. 
4. Weight correction for clothing 
The authors of the RWT method recommend using a child's 
nude weight in the regression equation. The weights given in 
patient charts were not specified and were used uncorrected. 
5. Adult Stature 
Although the RWT regression equations specify stature at 
18 years, the correction factors which provide final adult 
stature were used for this study. Since all of the patients 
in this study should have completed their growth (all but one 
were over 20 years and subjects who were aware of any growth 
over the last year were excluded), this seemed appropriate. 
However, the correction factors to final adult height may be 
misleading for subjects with growth disorders (i.e., 
correction may be too small for girls with genetic tall 
stature and too large for subjects with genetic short 
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stature). Since the correction factors are quite small (0.8 
cm for boys and 0.6 cm for girls), this is not believed to 
have contributed a significant amount of error. 
C. Sources of Bias 
1. Agreement to Participate 
Only a small fraction (4%) of those contacted actually 
refused to participate in the study. Reasons for refusal 
commonly seemed to involve feelings of disappointment in 
failure to achieve a predicted or desired height. In a few 
cases, the potential subject was never contacted because 
parents preferred to avoid bad memories associated with the 
clinic visits; some parents refused to tell the former 
patient about the study. For six of these non-participants, 
a reported height was obtained (usually from a family 
member); the mean reported height of these 6 male non¬ 
participants was 66.8 in (SD 3.2 in). Although this group is 
very small, their mean height is not significantly different 
from that of male participants (66.3 in, with SD 3.0 in) 
providing no evidence of a selection bias on the basis of 
height. 
The number of people who agreed to participate but 
didn't was quite large. Some of these may have had negative 
feelings about their stature (perhaps the shorter ones) and 
therefore did not participate, creating a more subtle height- 
related selection bias. 
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D. Relative reliability of Prediction Methods 
In order to be clinically useful, a prediction method 
must meet some standard of accuracy and precision. However, 
most authors do not quantify what they consider "adequate" 
accuracy or precision for a prediction method. For those 
methods which have been shown to have a known degree of bias 
in a given population, their utility may depend on the 
direction of that bias. For example, if two methods have the 
same mean error, but one overpredicts, and one underpredicts, 
they may not be equally useful. For children who are 
destined to be short adults, an erroneous overprediction may 
make adjustment to short stature more difficult. For 
children who are evaluated for excessive height, an 
underprediction may have a similarly adverse effect. Since 
so little published data are available on the accuracy of 
prediction methods for children with growth disorders, 
establishing stringent standards of accuracy is probably not 
warranted at this time. However, the relative accuracy and 
precision of the methods being considered can be evaluated. 
The reasons for the discrepancies between the results of 
this study and those of Lenko (1979, 1982) are not known. 
Based on the Lenko work, the GL, BP, and RWT methods should 
provide comparable results for the boys with constitutional 
delay. As shown in Figures 3 and 4, the GL and BP methods 
are considerably less accurate and less precise than RWT. In 
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the Lenko studies, bone age estimates were done for the 
entire population by two individuals, whereas the bone age 
estimates used in the current study were assessed by many 
different readers, not all within the same institution. This 
could contribute to the greater precision of the GL method 
reported in the Finnish studies. In addition, the Finnish 
bone age estimates were corrected for known differences 
between Finnish skeletal maturation and the Greulich and Pyle 
standards, improving the accuracy of their predictions. 
The Greulich and Pyle standards have been reported to be 
markedly advanced compared to the average maturity of 
American children (Roche, 1986). This would be expected to 
result in a bone age estimate which is more retarded than a 
child's true bone age, producing a falsely high adult height 
prediction in the GL method. In fact, the GL method was 
found to overpredict adult height for most groups in this 
study. It seems likely that correction of bone age standards 
and reducing the number of bone age readers would improve the 
method's precision. 
These problems with bone age estimation would be 
expected to selectively decrease the accuracy of the GL 
method compared to the BP method, which was developed based 
on the Greulich and Pyle standards, so any differences 
between these standards and the population would be cancelled 
out. The RWT method employs a greater number of variables, 
so inaccurate bone ages would affect RWT predictions least of 
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all (especially at older ages, when bone age contributes less 
to overall prediction accuracy). 
Zachmann and colleagues (1978) reported that the RWT and 
TW methods were better than BP for children with genetic tall 
stature. Review of their data reveals that the differences 
between the three methods were small, and the sample size was 
also small (5 boys and 6 girls). In this study, all seven of 
the genetic tall stature patients were girls, and the RWT and 
BP methods were roughly comparable. Both studies demonstrate 
a tendency for the RWT method to underpredict; this study 
showed overprediction of BP in contrast to the results of 
Zachmann et al., where the error of the BP method was 
symmetric about zero. 
Because of the need for rapid followup, predictions are 
often used instead of actual adult heights to assess the 
effectiveness of treatment (Colle et al., 1977; Martinez et 
al., 1987; Schoenle et al., 1987). In such studies, it 
should be clearly stated that results are preliminary, 
awaiting the final adult heights. A treatment may alter 
height predictions without affecting adult heights. 
Likewise, predictions may not change with treatment but adult 
height may be affected (Martin et al., 1986). Because of the 
availability of GH in ample quantities, there will be greater 
need and opportunity to answer questions regarding the use of 
GH in nondeficient children and in Turner's Syndrome, and its 
optimal dose, frequency, and route of administration. Adult 
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height prediction will undoubtedly play a major role in 
answering these questions. In view of the results of this 
study, it seems prudent to recommend caution in interpreting 
results which are based only on changes in height 
predictions. Further study and refinement of prediction 
methods may allow their use in such studies; however, the 
best way to assess the efficacy of treatment is to obtain 
adult heights of treated and untreated patients. 
E. Psychosocial Impact of Unusual Stature 
Given the previously discussed evidence that short 
stature may impair personality development and result in 
overprotective parenting (Rotnem et al., 1977, 1979), it is 
not surprising that some of the former patients expressed 
negative feelings about their growth and that some parents 
refused to inform their children about the study. However, 
evidence of good adjustment to abnormal stature was more 
commonly encountered. Since most of the subjects attained a 
technically normal adult height (although many experienced a 
transient lag behind their peers), a good adjustment would be 
expected for this population as a whole. 
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VII. CONCLUSIONS 
As hypothesized, the GL prediction method is associated 
with a larger error than the other two methods, and is not 
found to be the most precise prediction method for any 
diagnostic group. However, in contrast to the hypothesis, 
the GL method appears to be less accurate than the other two 
methods. For two diagnostic groups its accuracy was 
comparable to that of other methods (girls with genetic tall 
stature and boys with genetic short stature). For the 
largest group in the series, boys with constitutional delay, 
the GL method was the least accurate and least precise 
(Figures 3 and 4). The range of 67% confidence of 6 inches 
is too large to be desirable for clinical use. 
In general, the Genel/Lenko method was found to 
overpredict; the only underprediction which occurred was for 
girls with genetic tall stature (Figure 12). In clinical 
practice, if the GL method were used, the BP method would 
probably also be used (it entails no additional expense and 
little trouble). The two methods tend to demonstrate 
opposing biases: when one overpredicts, the other 
underpredicts (with some exceptions for boys). Using both of 
these methods together could perhaps be helpful to clinicians 
who are aware of the biases, and could therefore arrive at an 
intermediate prediction estimate. The accuracy and precision 
of the GL method may be improved with more accurate bone age 
estimation (i.e., done at one center and read by a limited 
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number of experienced radiologists). 
The BP method's accuracy compares favorably to RWT for 
both sexes in general and specifically for girls with 
constitutional delay. It was rarely demonstrated to be the 
most precise method, although its precision was comparable to 
that of the other two methods for girls. The BP method 
underpredicts for girls (except for those with genetic tall 
stature) and overpredicts for boys (except for those with 
combined constitutional. delay and genetic short stature, 
genetic short stature, and growth hormone deficiency). 
The RWT method is generally the most precise of the 
three methods compared in this study. This may be due in 
part to the large number of variables included in the RWT 
predictions. For boys, the RWT method is very accurate, and 
is the most reliable method for the groups with 
constitutional delay and combined constitutional delay and 
genetic short stature. However, the RWT method is never the 
most accurate method for girls in any diagnostic group and is 
the least accurate method for girls overall. 
Based on the results of this study, the recommended 
prediction method for boys with constitutional delay and 
combined constitutional delay and genetic short stature is 
the RWT method. For boys with genetic short stature, the GL 
and BP methods are comparable, and when used together may 
provide the best results. For girls, the BP method is the 
method of choice since it appears to be the most accurate; 
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however, its precision is comparable to the other two 
methods. 
The psychosocial aspects of growth evaluation appear to 
have played an important role in the personality development 
of the patient in this study. Although most subjects seemed 
to be quite well-adjusted, many subjects continued to have 
strong feelings about their size and/or treatment, even after 
many years. Effective counseling, including accurate adult 
height prediction, is therefore a necessary element of the 
management of children with growth disorders. 
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VIII. TABLES 
Table 1. Results of Initial Letters Sent to Former Patients 
Numb e r P e rcenta ge 
Data obtained from: 
clinic measurement 22 
home measurement 62 
reported height 35 
Total 119 3 5% 
No data obtained: 
Refused to participate 13 4% 
Lost to followup 206 61% 
TOTAL contacted 338 

60 
Table 2. Accuracy of Reported Heights vs. Measured Heights* 
Height 
Reported by n 
Mean 
Measured 
Height (in) 
Mean 
Reported 
Height (in) 
Mean 
Difference 
Rept-Meas.(in) 
Subject 
Verified 19 64. , 2 64. , 4 0. . 0 
in Clinic (4. 2) (4. 1) (0. ■7) 
Verified 35 65 . , 9 66. . 0 0. .2 
at Home (3. 9) (3. .8) (0. .8) 
Total 54 65 . 4 65 . . 5 0. . 1 
(4. 0) (4. 0) (0. ■7) 
Family Member 
Verified 1 67 . 1 68. . 0 0. . 9 
in Clinic 
Verified 15 67 . 4 67 . . 8 0. . 4 
at Home (3. 6) (3. 4) (0. 9) 
Total 16 67 . 4 67 . , 8 0. 4 
(3. 5) (3. 3) (0. 9) 
* Standard deviation in parentheses. 

61 
Table 3. Diagnoses of Study Participants 
Diagnosis Number Percentage 
Boys Girls Boys Girls 
Constitutional Delay 36 7 43 20 
Constitutional Delay & 
Genetic Short Stature 18 1 21 3 
Genetic Short Stature 16 6 19 17 
Growth Hormone Def. 4 1 5 3 
Genetic Tall Stature -- 8 23 
Turner's Syndrome -- 3 -- 9 
Miscellaneous 10 9 12 26 
Total 84 35 
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Table 4. Short stature patients, 1971-1976 
Diaqnosis Number Percent 
Boys Girls Boys Girls 
Constitutional delay 159 12 61 11 
Familial Short Stature 44 22 17 20 
Familial Short Stature 
and Constitutional Delay 34 45 13 42 
Constitutional/Primordial 
/Idiopathic Short Stature 22 16 8 15 
Chromosomal 1 13 <1 12 
Total 260 108 
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Table 5. Age Distribution of Study Participants 
Aqe Group Number Percent 
2-8 yrs. 1 1 
8-14 yrs. 67 56 
14-18 yrs. 51 43 
Age Distribution of Clinic Patients, 1971-1976* 
2-8 yrs. 31 
8-14 yrs. 44 
14-18 yrs. 25 
data from Finch, 1978 
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Table 6. Mean Adult Height by Diagnosis 
Mean Adult Height in inches* 
Diagnosis Boys Girls 
Constitutional Delay 68.1 62.6 
(2.7) (1.7) 
[36] [7] 
Constitutional Delay 65.9 60.6 
and Genetic Short Stature (1-8) 
[18] [1] 
Genetic Short Stature 64.5 58.7 
d-9) (1-0) 
[ 16] [6] 
Growth Hormone Deficiency 66.1 62.0 
(1.6) -- 
[4] [1] 
Genetic Tall Stature — 71.5 
(1-8) 
[8] 
Other 63.9 59.0 
(4.0) (2.8) 
[10] [ 12] 
TOTAL 66.3 62.6 
(3.0) (5.4) 
[84] [35] 
U.S. General Population' 69.6 64.4 
standard deviation in parentheses (); sample size 
brackets!] 
* mean adult height at 18 years; from Hamill et al., 1979 
in 
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IX. FIGURES 
LEGEND 
Figures 1-12. The mean prediction errors (+_ one standard 
deviation) corresponding to each diagnostic group are plotted 
according to method. Overpredictions (predicted height 
greater than actual height) are positive; underpredictions 
are negative. 
Figures 13-18. The absolute value of the individual 
prediction error for each participant is plotted against age 
at prediction, for each of the three prediction methods. 
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Figure 11 
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XI. APPENDICES 
APPENDIX A Introductory letter sent to former patients 

YALE UNIVERSITY 
SCHOOL OF MEDICINE 
SECTION OF PEDIATRIC ENDOCRINOLOGY 
DEPARTMENT OF PEDIATRICS 
P.O. BOX 3333 
NEW HAVEN. CONNECTICUT 06510-80M 
AREA CODE 203: 785^648 
WILLIAM V TAMBORLANE.JR , M D. D.mior 
MYRON GENEL, M D , Assoc Dean 
MARTIN PRESS, MB..MR CP 
THOMAS CARPENTER, M D 
FLORENCE COMITE, M D 
PATRICIA DAVIS, R N , MSN 
CYNTHIA TORONY-GRANFIELD, R N 
BETH REILLY-ROMAN, R.N 
Because you were seen in our clinic for evaluation of your growth 
several years ago, we are writing to you now to request your help in 
a study, of growth in children. We are trying to determine the best way 
to.predict a child's adult height, in order to give the best advice to 
children we see now. Since we know what your adult height was predicted 
to be when you were seen in clinic, we would like to know your actual 
adult height for comparison. 
The best way to obtain your current precise height is for you to come 
to clinic to be measured. This visit will be very brief, and will help 
us immensely. There will be no charge for this visit. If you are 
unable to come for measurement, you can still be of help by having some¬ 
one measure you.carefully at home, and sending us the result. All results 
of this study will be completely confidential. 
We will call you within two weeks to answer any questions you may have 
and invite your participation in the study. You are free to decline 
without affecting your current or future relationships with doctors at 
Yale New Haven Hospital. 
Thank you in advance for your cooperation. 
Sincerely yours, 
Irene Freeman 
Yale Medical Student 
Myron Genel, M.D. 
Professor of Pediatrics 

APPENDIX B Home measurement instructions 
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HOME MEASUREMENT INSTRUCTIONS 
Please follow these instructions as carefully as possible; this will provide 
the most accurate measurement and ensure that all subjects in our study 
follow the same procedure. We ask you to do the measurement 3 times, as a 
check of your original measurement. Do not be concerned if the 3 values 
differ; this is to be expected, and we will use the average. 
Because people may shrink as much as ■§-" over the course of the day, the best 
time for measuring is early in the morning, within an hour of getting up. 
Please record the time of day the measurement was done, and how long you had 
been out of bed at that time. 
1. Take your shoes and socks off and choose a wall with a bare floor. If 
you can find a spot with a vertical line on the wall (e.g. a wallpaper seam), 
this can serve as a guide to keep the tape measure straight during measurement. 
2. Stand as straight and tall as you can, with your head and back against 
the wall. The heels of your feet should be together and touching the wall, 
and you should be looking straight ahead. 
3- Have the measurer put his hands on your lower jaw, right in front of 
your ears, and with gentle upward pressure pull your head up. This stretches 
your backbone to achieve your full height. 
4. Have the measurer place a flat surface (e.g. book, board) on top of your 
head and perpendicular to the wall. It is very important to hold the surface 
perpendicular to the wall (parallel to the floor) because any small change 
in angle may cause a significant change in the measurement. If the measurer 
is shorter than you, he should stand on a stool or chair in order to see well 
enough to be sure the surface is perpendicular to the wall. 
5. With a soft pencil, make a small mark on the wall where the surface in 
contact with the head touches the wall. 
6. Carefully measure the distance from the floor to the pencil mark, using 
a tape measure. Record measurement #1 to the nearest millimeter or nearest 
1/8-. 
?. Erase the pencil mark and repeat the measurement twice; record these 
values. Fill out the enclosed postcard and mail. 
Thank you very much for your help in our study of adult height prediction 
in children. You have been a big help! 
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APPENDIX C Data 

Nshh 3 Se ■ • OPS # dob Dx: Height Ft edict-ions Differences »\1 lit <r 
pred!n 
GL BP RWT GL BP RWT 
(in! (in! (in) (i n) (in) (in) (in! !yr) 
Clin :c raeasureraerts (n=22) 
R.A. 097-18-88 098468 CD 70.4 C 78.0 70.5 69.8 -1.6 -0.1 0.6 13.3 
R.A. K 096-03-84 031363 CD 63.1 c 66,2 62,8 64.8 -3.1 0.3 -1.7 13,1 
B.B. H 093-07-18 110768 CD/BSS 67.1 C 68.5 65.9 6E.1 -1.4 1.2 -1.0 18.5 
S.B. r 078-87-75 048760 CD 67.6 C 71.5 67.5 66.9 -3.9 0.1 0.7 ■ ? r' 
R.E, H 066-38-8? 090460 4 58.6 c 71.0 67.9 . 65.1 -12.4 -9.3 -6.5 13 = 1 
S.B. H 097-86-50 080364 CD 66.1 C 69.0 67.6 68,0 -2.2 -1.5 -1.9 i 6. j 
T.B, F 101-55-55 053066 BIS 74.4 c 72.0 75,3 71.9 8,4 -0.9 2.5 11.7 
S.C. h 087-67-37 090860 END 67.1 c 68.0 69.7 67.3 -e.c -8.6 “. C 13.2 
H.C. F 091-68-86 018665 PGF 56.3 c 59.5 57.7 61.6 -3.2 -1.4 -5.3 9.8 
A.C. 11 093-59-58 078060 c J 65.9 c 69.0 66.5 67.5 -3.1 -8.6 -1.6 15,0 
J.C. R 070-83-83 091067 CD 62.8 c 74.0 64.1 -11.8 -1.9 5.9 
T.C. H 115-07-49 108966 CD 70.9 c 71,0 71.0 68.9 -0.1 -0.1 2.0 15.6 
F.D. N 057-19-74 041168 CD/BSS 66.6 c 68.0 63.5 65.7 -1.4 3.1 0.9 9.9 
H.D. ,1 067-10-01 071166 5SS 68.0 c 66.5 65,9 66.9 1.5 8.1 1.1 11.6 
P.D. R 087-33-58 030557 SS 63.8 c 65.0 64.2 66.5 -1,2 -0.4 -2.4 16.3 
C.D. H 089-16-18 181768 BHD 65.2 c 69.0 65.3 67.5 -3,8 -0.1 -8.3 18.6 
f!.E. M 098-84-70 100967 CD/GSS 62.4 c 64.0 59.5 63.0 -1.6- 8 = 9 -0.6 9.4 
H.F. F 094-36-58 181760 CD 64.8 c 64.4 62.1 0.4 2,7 14.8 
J.G. F 108-90-71 060865 CD CSS 60.6 c 62.0 59.5 62.3 -1.4 1.1 -1.7 12.9 
N.K. F 085-86-56 010655 SS 57.4 c 58.0 58.0 -0.6 -0,6 17,9 
G.K. « 097-60-43 071967 CD/SSS 65.8 c 68.5 65.5 64.5 -3.3 -0.3 0.7 9.3 
E.L. F 105-40-56 093064 OSS 57.4 c 57.5 56.8 -0.1 0.6 14.6 
Avg, Clinic seasured 64.6 67.0 65,0 66.3 -2.4 -0.3 -1.0 12.6 
S.D., Clinic seasured 4.5 4,5 4.8 2.5 3.5 £ .6 8.2 2,6 
Horae seasuresents (n=6E) 
A.A. H 088-87-95 071163 CD 65.2 H 74.5 72.1 69.7 -9.3 -6.9 -4.5 10.3 
K.A. F 113-76-16 071966 TS 57.7 H 60.5 59.0 -2.8 -1.3 15 = 4 
C.E. F 097-56-16 038765 1 65.0 H 66.0 65.2 64.9 
-1.0 -0.2 0.1 11.6 
J.E. H 085-80-73 081959 CD/GSS 67.1 H 66.0 65.6 67.1 1.1 1.5 0.0 13.1 
J.B. 11 107-60-40 180165 CD 67.5 H 68.0 67.4 67.3 -0.5 0.1 0.8 14.1 
B.B. F 064-79-04 110768 8 56.5 H 55.0 58.2 58.7 1.5 4.3 -2.8 9.8 
S.B. h 091-89-73 090363 CD/GSS 66.5 H 70.0 67.3 65.6 -3,5 -0.8 0,9 11.2 
F'.B. H 106-36-06 060865 IBD/7CD 65.0 H 67.5 66.3 67.4 -8,5 -1.3 -2.4 14,3 
S.B. M 098-58-61 082860 CD 65.4 H 69.0 68.5 65.7 -3.6 -3.1 -0.3 14.7 
J.B. f! 106-80-94 080967 CD/SSS 65.1 H 67.0 64.0 65.0 -1.9 1.1 0.1 18.8 
F'.B. F 061-00-37 01876! TS 54.1 H 59.5 56.1 59.4 -5.4 -2.0 “5.3 12.5 
C.B. M 089-64-81 103061 CD 66, e H 65,5 63,2 65,4 1.3 3.6 1.4 12.4 
J.B. fl 095-73-39 050968 CD 71.3 H 69,5 69.8 70.7 1.8 1.5 0,5 13.9 
H.B. H 188-65-38 081767 CD 74.1 H 72.5 1.6 17,1 
S.B. H 105-37-03 071568 CD 66.9 H 70.0 68.9 -3,8 -2.1 16.3 
S.B. F 081-81-46 088163 GTS 73.0 H 73.5 74.8 72.0 -0.5 -l.S 1.0 11.6 
J.B. u 110-79-39 051866 CD 67.0 H 69.0 68.6 68.1 -8.0 -1.6 -i.i 14.6 
E.C. F 083-41-60 101860 G'SS 59.3 H 60.0 57.8 61.0 -0.7 2.1 -1.7 11.3 
A.C. 11 105-53-07 031667 GSS 68.3 H 65,0 64.0 64.4 -2.8 -1.6 -2.8 13.2 
S.C. F 070-18-98 010865 NF 59.8 H 62.5 60.0 61.7 -8.7 -0.8 -1.9 8.1 
J.C. H 067-74-83 091064 CD 67.3 H 71.5 70.5 70.3 -4.3 -3.3 -3.0 13.9 
S.C. F 100-11-66 080163 GTS 69. E H 72.5 72,4 71.6 -8.7 -2.6 -i.e 14,0 

K.C. ft 088-25-31 031461 CD 70.5 H 77.0 75.4 71.8 -6.5 -4.9 -1.3 12.7 
J.D. .1 113-41-98 013165 GSS 60.5 H 60.5 60.7 0.0 -0,2 16.8 
J.D. H 101-50-58 042663 CD 71.8 H 73.0 73.3 71.9 -1.3 -1.5 0.3 14.8 
T.B. M 058-04-36 061358 GSS 64.3 H 66.5 65.1. 67.5 -2,2 -0.8 -3.2 14.2 
R.D. n 099-24-41 091864 1SS 63.0 H 66.5 64.9 65.5 -3.5 -1.9 -2.5 12.7 
J.E. n 080-27-95 061063 CD 68,6 H 68.5 68,2 69.8 1.1 1.4 0.4 14.E 
S.E. F 093-06-6? 090561 GTS 72.0 H 71.0 78.0 71.8 1.0 0,0 0.2 13.9 
E.F. r 104-66-60 111867 CD 63.6 H 65.5 63.4 65.1 -1.7 0.4 -1,3 11.3 
K.F. R 066-89-13 050457 CD 69,5 H 71.0 72.1 68.8 -1.5 *E .6 0.7 15,5 
3.F. H 085-72-46 012556 CD/GSS 67.6 H 66.0 64.8 65,6 1.6 2.8 2.0 14.8 
K.F. F 058-11-46 090762 NF 58,3 H 59.0 58.2 -0.7 0.1 15.4 
L.F. M 119-47-96 092366 GSS 65.0 H 64.0 63,6 1.0 1.4 17,0 
E.F. F 051-19-71 060759 GSS 60.4 H 60.0 59.0 0,4 1.4 15,4 
B.F. F 094-31-31 103161 CD 63.3 H 63.5 63.3 63.7 -0,3 -0.0 A C "V . J 14,0 
J.G. H 103-46-73 103163 CD 67.5 H 68.0 67.0 68.0 -0.5 0.5 -0.5 14.9 
R.G. M 104-45-79 022465 GSS 66.0 H 68.0 67.6 68,4 -2.0 -1.6 -2.4 13.9 
J.G. F 100-74-51 110866 EP 62.0 H 66.5 65,6 66.1 -4 = 5 -3.6 -4.1 11.0 
J.G. H 100-74-52 092364 CD 70.0 H 69.0 68.6 68.3 1.0 1.4 1.7 13,1 
S.S. H 114-75-24 O80366 CD/GSS 66.0 H 68.0 66.4 -2.0 -0.4 15,7 
D.G. F 102-58-66 042564 GTS 63.7 H 67.0 67,9 1.7 o.e 14.4 
D.G. H 101-33-95 030363 CD 70.3 H 69.5 69.6 66.5 o.e 0.5 1.8 14.£ 
D.G. il 067-97-07 091366 GSS 63.5 H 65.5 63,7 65.2 -2.0 -0.3 -1.7 10,4 
D.G. R 111-43-19 022367 GSS 65.6 H 65.0 0.8 
D.G. H 110-33-26 021567 CD 67.3 H 69.0 68.6 69.7 -1.8 -1.3 -8.5 13.8 
N.G. n 064-20-61 031361 CD/SSS 64.5 H 65.0 64.0 65.3 -0.5 0.5 -0,8 13.6 
F.H. R 113-16-14 020569 CD 65.0 H 66,5 64.4 65.9 -1.5 0.6 -0.9 12.6 
R.H. H 093-49-20 091259 CD 67,2 H 68.5 6d. 6 66.1 -1.3 -1.4 1.1 15.8 
P.H. H 113-33-94 111366 CD/GSS 67.6 H 66.5 66,3 1.1 1.3 14.9 
ft.I. H 075-48-03 032164 GSS 64.9 H 65.5 64.7 66.7 -0,6 0.2 -l.B 11.1 
L.J. F 106-79-95 091766 ASTHMA 61.1 H 59.5 57.9 61.3 1,6 3.2 -O.E 13.1 
S.K. F 094-31-35 071163 CD 62.8 H 63.5 61.8 -0.7 1.0 14.2 
D.K. H 059-15-05 03o6t'3 CD/GSS 67,5 H 66.0 64.8 66.0 1,5 2.7 1.5 14,4 
K.K. F 090-83-15 080463 TS 58.6 B 63.0 60.2 63.7 -4.4 -1.6 -5,1 10.1 
V. K. r 099-32-50 052363 GTS 78.8 H 78.0 72,9 78.8 0.8 -0.1 0.0 14.0 
r.k. R 065-43-36 092460 3 63.0 H 65.0 66.2 -2.0 -3.8 15.3 
ft. K. fi 112-41-33 122664 GSS 62.6 H 68.5 62.6 0.1 0.0 16.5 
D.L. F 070-64-39 101965 GTS 70.5 H 70.5 70,4 70,6 0.0 0.1 -0.1 13.3 
F.L. H 112-41-39 021966 GSS 64.5 H 66.5 64,1 66.8 -2,0 0.4 -1.7 * c q 
T.L. R 101-33-i4 071064 CD/GSS 66.3 B 64.0 62.1 66.1 2.3 4.1 0.2 13.5 
J.R. H 061-11-15 111561 CD/GSS 65.8 H 66.0 64.8 65,9 -0.3 1.0 -0.2 14.3 
fivg., Hose aessured 65,5 66,7 65.6 66.8 -1,1 -0.2 -0.9 13.7 
S.D., Hose seasured 4.8 4.2 4.8 3.1 2.2 2.1 1.8 1.9 
fivg, total aeasured 65.3 66.8 65 = 4 66,6 -1.5 -0.2 -0,9 13,4 
S.E,, tota seaeured 4.3 4.3 9.8 3.0 2.7 c. E 1,9 2.2 
Reported height (n=35) 
•J •. H F 091- -57- -54 041965 GSS 59.0 R 58.0 57.3 61.3 1.0 1.3 -2 = 3 12 ,3 
J.F. F 100- -21- -89 082362 GSS 58.0 F: 57.0 56,6 1.0 1,4 15 = 0 
T.a. « 113- -41- -96 121367 ESS 64.0 R 66,0 65.1 66.8 -2.0 -1,1 -2.8 13 ,8 
G.A. R 069- -14- -80 042667 CD 67.5 F 69.0 63.6 67.7 -1.5 -1.1 -0,2 14 « -j 
W.B. r 103- -52- -50 USiE63 CD 59.0 R 61.0 59.1 -2.0 -0.1 1 3 .1 
K.B. F 088- -61- -16 051167 HI Y POP IT 61.0 F. 5E.5 54.9 61.0 2,5 6.1 0.0 11 
R.B. pi 093- -83- -39 071964 CD/GSS 65.5 R 63.0 61,2 63.2 2.5 4.3 2.3 ii .0 
T.B. j- 079- 
-41- -92 010367 BHD 6 8,0 P 66, u 64,9 67.3 2.0 3.1 0.7 . d .6 

A.E. M i14-19-24 092666 ?CB 69.5 R 68.0 67.6 1.5 1.9 15,3 
C.B. F 064-35-18 061058 CD 63.0 F; 65.5 64.1 64,1 -2.5 -1.1 -1.1 14 = 0 
K.B. F 102-05-92 012465 GTS 70.5 R 71,0 ?1.4 70.5 -0.5 -0,9 0.0 13.2 
J. E. 095-59-91 010263 CD 68,5 R 70,0 63.6 68.7 -1.5 -0.1 -0.2 13.2 
n.c. 100-51-14 122062 ?gq 70.3 R 69.0 69.3 70.5 1.8 1.5 0.3 14,8 
H, C. *. 085-26-80 010865 6 58.0 R 65.5 62.7 62.6 -7.5 -4.7 -4.6 9 = 8 
6.D. K U 6 c—19 - 8 6 120660 71 61.0 F L1 z G -t. J 61.6 64.1 r r . J -0.6 -3.1 11.3 
S.D. r 065-14-3? 082465 CD 61.8 R 63.5 60.6 64.3 -1.8 1.1 -2.5 i 1 c i - * xJ 
K.B. H 106-99-5? 102364 CD/GS5 67.5 F 67.5 65,8 67.1 0.0 1.7 0.8 15,0 
D.r. K 102-76-16 0705:8 CD 71.0 R 68,5 67.3 2.5 -• *7 16.0 
S.D. h 087-24-93 051561 ess 6". 5 R 64.5 65.3 67*5 3.0 2.2 0.3 1 £, 6 
D.F. r 057-46-40 052662 CD 67.5 p 67.5 67.? 67.? 0.0 0.1 0.1 14.4 
D.F. H 058-54-32 111662 CD-'623/ 61.0 R 69,0 64.8 64.8 -8.0 -3.8 -S 0 ■J r U 11.0 
R.F. F 058-0--55 081062 E5E 58.0 R 61,5 5°. 2 61.6 “3 * 5 -1,2 -3.6 y.B 
fi.F. F 089-64-06 11026” 6HD 62.0 R 61.C 60.5 61.6 1.0 1.5 0.8 12.E 
£.6, « 043-01-84 112157 CD 68.5 R 68.0 67.4 67,2 0.5 1.1 1.3 14.0 
C.S. il 115-26-45 021866 CD 67.0 R 70.0 69.8 -3.0 -2.6 16.3 
J.S. f! 087-78-86 071356 CD 72.0 R 68.5 2.5 17.0 
H.H. H 061-25-78 021064 sss 66.0 R 65.5 63.9 64.7 0,5 2,1 1.3 13,0 
R,H. K 112-92-30 053165 CD 72,5 R 73.0 74.0 -0.5 -1.5 16,3 
C.I. H 084-35-34 041463 CD 67.5 R 72.0 70.6 66.6 -4.5 -3.1 0.9 8.2 
K.J. H 094-21-61 010362 CD 65.5 R 64.5 62 = 8 66.2 1.0 2.7 -0.7 13,7 
P.K. « 110-93-56 070463 sss 62.5 R 61.0 61.0 1.5 1.5 17,5 
K.'.. H 093-32-56 11235? CD 63.0 R 65.0 63.6 62.6 -2.0 -0.6 0.4 16.0 
J.K. H 062-70-01 09206? cd/ess 67.0 R 70.5 70.9 68.4 -3.5 -3,9 -1.4 14.4 
.I.L. H 117-04-66 090966 GSS 64,5 R 64.0 63.1 0.5 1.4 16.3 
R. H. ’ H 053-26-08 04*560 6 HD 64.0 R 65.5 63.7 63.2 -1.5 0.3 0.8 15,9 
Avg., repor ted 65.1 65.8 6?.4 65.6 -0.7 0.2 -0.4 13,8 
S.D., reported 4.1 3,9 4,5 2,7 2.7 2:3 1.9 2.1 
Avg,, TOTAL . (n=119} 65.2 66.5 65.1 66,3 -1.2 -0.1 -0.8 13,5 
S.D,, TOTAL 8.2 4.2 4.0 2.9 2.7 2.3 1.9 2,2 
C-clinic aeasureient 
H=hcse sseasureient 
R=repc‘fted by subject 
F=rsported by family seiber 
C D=c o r. s 111 u t i o n a I deia y 
6HD=growtf< horeone deficiency 
GSS=genetic short stature 
GTS-genstic tall stature 
IBD=infla*ffiatory bowel disease 
!SS=idiopathic short stature 
disc 
l=hypotpit, S/P cranio 
c=!iiultifocal eosinophilic granulosa with idiopathic short stature 
3=B1 aci fan-Diamord Syndroase/CB/Steroid F:t 
4=adrenai hypoplasia, hypogonadism (autoiasunel 
5=thalassesia intersedia with delayed adolescence 
6=?CD/priffiordial dwarfiss 
7=Noonan s syndrose 
NF=r.eurofibrosatosis 
P6fi=possible growth arrest 
PGF=primordial growth failure 
PF-precocious puberty 

SS=short stature 
TS-Turner:5 Syndrose 
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